Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best ...

Oncimmune, a precision medicine company spun out from the University of Nottingham, has fallen into administration.

The company’s impact extends beyond regulatory innovation, contributing significantly to the regional economy by positioning Belfast as a global hub for precision medicine expertise. Through job ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

When someone is traumatically injured, giving them blood products before they arrive at the hospital—such as at the scene or ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

InformedDNA ®, a precision health company revolutionizing the application of genomic insights, today announced the acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and ...

The Association of Cancer Care Centers (ACCC), in collaboration with Eli Lilly and Company, is pleased to announce the seven recipients of the "Improving the Precision Oncology Care Pathway" Request ...

the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann ...

We couldn’t be more excited to back them on this journey.” About Ataraxis AI Ataraxis is an AI precision medicine company transforming patient outcomes through the power of artificial ...